The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.
Open accessAbstract
PR-39, a proline/arginine-rich peptide antibiotic, has been purified from pig intestine and later shown to originate in the bone marrow. Intending to isolate a clone for a human counterpart to PR-39, we synthesized a PCR probe derived from the PR-39 gene. However, when this probe was used to screen a human bone marrow cDNA library, eight clones were obtained with information for another putative human peptide antibiotic, designated FALL-39 after the first four residues. FALL-39 is a 39-residue peptide lacking cysteine and tryptophan. All human peptide antibiotics previously isolated (or predicted) belong to the defensin family and contain three disulfide bridges. The clone for prepro-FALL-39 encodes a cathelin-like precursor protein with 170 amino acid residues. We have postulated a dibasic processing site for the mature FALL-39 and chemically synthesized the putative peptide. In basal medium E, synthetic FALL-39 was highly active against Escherichia coli and Bacillus megaterium. Residues 13-34 in FALL-39 can be predicted to form a perfect amphiphatic helix, and CD spectra showed that medium E induced 30% helix formation in FALL-39. RNA blot analyses disclosed that the gene for FALL-39 is expressed mainly in human bone marrow and testis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACETYLORNITHINASE OF ESCHERICHIA COLI: PARTIAL PURIFICATION AND SOME PROPERTIES
Vogel, H. J., & Bonner, D. M. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65874-0 · Cited by 3,991
Merrifield, B. (1986) · Science · doi:10.1126/science.3961484 · Cited by 1,005
Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian Cells
Lehrer, R. I., Lichtenstein, A. K., & Ganz, T. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.000541 · Cited by 991
Boman, H. G., Agerberth, B., & Boman, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2978-2984.1993 · Cited by 551
Self-citationPaneth cells of the human small intestine express an antimicrobial peptide gene
Jones, D. E., & Bevins, C. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50079-x · Cited by 534
Primary structures of three human neutrophil defensins.
Selsted, M. E., Harwig, S. S., Ganz, T., Schilling, J. W., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112121 · Cited by 534
Crystal Structure of Defensin HNP-3, an Amphiphilic Dimer: Mechanisms of Membrane Permeabilization
Hill, C. P., Yee, J., Selsted, M. E., & Eisenberg, D. (1991) · Science · doi:10.1126/science.2006422 · Cited by 507
Insect immunity. Attacins, a family of antibacterial proteins from Hyalophora cecropia.
Hultmark, D., Engström, A., Andersson, K., Steiner, H., Bennich, H., & Boman, H. G. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01465.x · Cited by 442
Self-citationAGERBERTH, B., LEE, J., BERGMAN, T., CARLQUIST, M., BOMAN, H. G., MUTT, V., & JÖRNVALL, H. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16442.x · Cited by 348
Self-citationJones, D. E., & Bevins, C. L. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81160-2 · Cited by 341
Cited by
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Granules of the Human Neutrophilic Polymorphonuclear Leukocyte
Borregaard, N., & Cowland, J. B. (1997) · Blood · doi:10.1182/blood.v89.10.3503 · Cited by 1,522
Amphipathic, α-helical antimicrobial peptides
Tossi, A., Sandri, L., & Giangaspero, A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<4::aid-bip30>3.0.co;2-m · Cited by 1,247
Yang, D., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., Oppenheim, J. J., & Chertov, O. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1069 · Cited by 1,240
Neutrophil granules and secretory vesicles in inflammation
Faurschou, M., & Borregaard, N. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.09.008 · Cited by 1,162
Antibacterial peptides: basic facts and emerging concepts
Boman, H. G. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01228.x · Cited by 1,158
Self-citationAntimicrobial peptides: premises and promises
Reddy, K. V. R., Yedery, R. D., & Aranha, C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.005 · Cited by 1,068
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Cathelicidins, multifunctional peptides of the innate immunity
Zanetti, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403147 · Cited by 988
Sørensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S., & Borregaard, N. (2001) · Blood · doi:10.1182/blood.v97.12.3951 · Cited by 894
Mode of action of linear amphipathic α-helical antimicrobial peptides
Oren, Z., & Shai, Y. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<451::aid-bip4>3.0.co;2-f · Cited by 848
Frohm, M., Agerberth, B., Ahangari, G., Ståhle-Bäckdahl, M., Lidén, S., Wigzell, H., & Gudmundsson, G. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15258 · Cited by 803
Self-citationActivities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils
Turner, J., Cho, Y., Dinh, N.-N., Waring, A. J., & Lehrer, R. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2206 · Cited by 798
Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jörnvall, H., Wigzell, H., & Gudmundsson, G. H. (2000) · Blood · doi:10.1182/blood.v96.9.3086 · Cited by 758
Self-citationBals, R., Wang, X., Zasloff, M., & Wilson, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9541 · Cited by 746
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses
Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., & Hancock, R. E. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3883 · Cited by 713
Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37
Johansson, J., Gudmundsson, G. H., Rottenberg, M. E., Berndt, K. D., & Agerberth, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3718 · Cited by 661
Self-citationAnimal antimicrobial peptides: An overview
Andreu, D., & Rivas, L. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<415::aid-bip2>3.0.co;2-d · Cited by 618
Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B., & Salcedo, R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0325z.x · Cited by 578
Self-citationHeilborn, J. D., Nilsson, M. F., Sørensen, O., Ståhle-Bäckdahl, M., Kratz, G., Weber, G., & Borregaard, N. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12069.x · Cited by 572
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572
Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G. H., & Gallo, R. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01340.x · Cited by 567
Self-citationDegradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus -Derived Proteinases
Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wójcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M., Pohl, J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4673-4679.2004 · Cited by 551
Antimicrobial peptides: General overview and clinical implications in human health and disease
Guaní-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., & Terán, L. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.004 · Cited by 549
Human Antimicrobial Peptides and Proteins
Wang, G. (2014) · Pharmaceuticals · doi:10.3390/ph7050545 · Cited by 528
Epithelial antimicrobial peptides in host defense against infection
Bals, R. (2000) · Respiratory Research · doi:10.1186/rr25 · Cited by 498
Antimicrobial peptides and the skin immune defense system
Schauber, J., & Gallo, R. L. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.03.027 · Cited by 477
The Vitamin D–Antimicrobial Peptide Pathway and its Role in Protection Against Infection
Gombart, A. F. (2009) · Future Microbiology · doi:10.2217/fmb.09.87 · Cited by 456
Davidson, D. J., Currie, A. J., Reid, G. S. D., Bowdish, D. M. E., MacDonald, K. L., Ma, R. C., Hancock, R. E. W., & Speert, D. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1146 · Cited by 429
Cathelicidins - a family of multifunctional antimicrobial peptides
Bals, R., & Wilson, J. M. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2186-9 · Cited by 427
Gallo, R. L., Kim, K. J., Bernfield, M., Kozak, C. A., Zanetti, M., Merluzzi, L., & Gennaro, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13088 · Cited by 419
Di Nardo, A., Vitiello, A., & Gallo, R. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2274 · Cited by 405
A cathelicidin family of human antibacterial peptide LL‐37 induces mast cell chemotaxis
Niyonsaba, F., Iwabuchi, K., Someya, A., Hirata, M., Matsuda, H., Ogawa, H., & Nagaoka, I. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01398.x · Cited by 402
Antimicrobial Peptides: Old Molecules with New Ideas
Nakatsuji, T., & Gallo, R. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.387 · Cited by 394
The Role of Cathelicidins in the Innate Host Defenses of Mammals
(2005) · Current Issues in Molecular Biology · doi:10.21775/cimb.007.179 · Cited by 393
Shafer, W. M., Qu, X.-D., Waring, A. J., & Lehrer, R. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1829 · Cited by 391
Schauber, J. (2003) · Gut · doi:10.1136/gut.52.5.735 · Cited by 383
Impact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 374
From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides
Shai, Y., & Oren, Z. (2001) · Peptides · doi:10.1016/s0196-9781(01)00498-3 · Cited by 370
Bactericidal Activity of Mammalian Cathelicidin-Derived Peptides
Travis, S. M., Anderson, N. N., Forsyth, W. R., Espiritu, C., Conway, B. D., Greenberg, E. P., McCray, P. B., Lehrer, R. I., Welsh, M. J., & Tack, B. F. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2748-2755.2000 · Cited by 369
The human cathelicidin LL-37 — A pore-forming antibacterial peptide and host-cell modulator
Xhindoli, D., Pacor, S., Benincasa, M., Scocchi, M., Gennaro, R., & Tossi, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.003 · Cited by 366
Sørensen, O., Arnljots, K., Cowland, J. B., Bainton, D. F., & Borregaard, N. (1997) · Blood · doi:10.1182/blood.v90.7.2796 · Cited by 365
Frohm Nilsson, M., Sandstedt, B., Sørensen, O., Weber, G., Borregaard, N., & Ståhle-Bäckdahl, M. (1999) · Infection and Immunity · doi:10.1128/iai.67.5.2561-2566.1999 · Cited by 351
Membrane targeting cationic antimicrobial peptides
Ciumac, D., Gong, H., Hu, X., & Lu, J. R. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.10.103 · Cited by 351
Rosenfeld, Y., & Shai, Y. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.017 · Cited by 318
Antimicrobial Peptides: Current Status and Therapeutic Potential
Koczulla, A. R., & Bals, R. (2003) · Drugs · doi:10.2165/00003495-200363040-00005 · Cited by 306
Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide
Bals, R., Weiner, D. J., Moscioni, A. D., Meegalla, R. L., & Wilson, J. M. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.6084-6089.1999 · Cited by 302
Papo, N., & Shai, Y. (2003) · Peptides · doi:10.1016/j.peptides.2003.09.013 · Cited by 298
Hase, K., Eckmann, L., Leopard, J. D., Varki, N., & Kagnoff, M. F. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.953-963.2002 · Cited by 293
Coffelt, S. B., Marini, F. C., Watson, K., Zwezdaryk, K. J., Dembinski, J. L., LaMarca, H. L., Tomchuck, S. L., zu Bentrup, K. H., Danka, E. S., Henkle, S. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900244106 · Cited by 293
Biology and clinical relevance of naturally occurring antimicrobial peptides
Gallo, R. L., Murakami, M., Ohtake, T., & Zaiou, M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129801 · Cited by 291
Cathelicidin Anti-Microbial Peptide Expression in Sweat, an Innate Defense System for the Skin
Murakami, M., Ohtake, T., Dorschner, R. A., Gallo, R. L., Schittek, B., & Garbe, C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19507.x · Cited by 291
Structural features and biological activities of the cathelicidin-derived antimicrobial peptides
Gennaro, R., & Zanetti, M. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<31::aid-bip40>3.0.co;2-9 · Cited by 291
Diagnosis of Intra-amniotic Infection by Proteomic Profiling and Identification of Novel Biomarkers
Gravett, M. G. (2004) · JAMA · doi:10.1001/jama.292.4.462 · Cited by 288
Andersson, M., Gunne, H., Agerberth, B., Boman, A., Bergman, T., Sillard, R., Jörnvall, H., Mutt, V., Olsson, B., & Wigzell, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07150.x · Cited by 283
Self-citationAntimicrobial Peptides as Mediators of Epithelial Host Defense
Huttner, K. M., & Bevins, C. L. (1999) · Pediatric Research · doi:10.1203/00006450-199906000-00001 · Cited by 280
Yang, D., Chertov, O., & Oppenheim, J. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.5.691 · Cited by 279
Advances in antimicrobial peptide immunobiology
Yount, N. Y., Bayer, A. S., Xiong, Y. Q., & Yeaman, M. R. (2006) · Peptide Science · doi:10.1002/bip.20543 · Cited by 278
Antimicrobial peptides: natural effectors of the innate immune system
Radek, K., & Gallo, R. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0064-5 · Cited by 275
Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity
Ramanathan, B., Davis, E. G., Ross, C. R., & Blecha, F. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01549-6 · Cited by 268
Staphylococcus colonization of the skin and antimicrobial peptides
Otto, M. (2010) · Expert Review of Dermatology · doi:10.1586/edm.10.6 · Cited by 262
Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence
Zaiou, M., Nizet, V., & Gallo, R. L. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12132.x · Cited by 256
β-Defensins in Lung Host Defense
Schutte, B. C., & McCray, P. B. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.134340 · Cited by 258
Antimicrobial peptides important in innate immunity
Cederlund, A., Gudmundsson, G. H., & Agerberth, B. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08302.x · Cited by 256
Self-citationAntimicrobial skin peptides and proteins
Schröder, J. M., & Harder, J. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5364-0 · Cited by 253
Epithelial Antimicrobial Peptides: Review and Significance for Oral Applications
Weinberg, A., Krisanaprakornkit, S., & Dale, B. A. (1998) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411980090040201 · Cited by 253
Skerlavaj, B., Gennaro, R., Bagella, L., Merluzzi, L., Risso, A., & Zanetti, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28375 · Cited by 252
Wang, G., Mishra, B., Epand, R. F., & Epand, R. M. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.01.016 · Cited by 184
Cole, A. M., Shi, J., Ceccarelli, A., Kim, Y.-H., Park, A., & Ganz, T. (2001) · Blood · doi:10.1182/blood.v97.1.297 · Cited by 146
Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells
Schauber, J., Iffland, K., Frisch, S., Kudlich, T., Schmausser, B., Eck, M., Menzel, T., Gostner, A., Lührs, H., & Scheppach, W. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.05.005 · Cited by 109
Implications of the Innate Immune Response to Adenovirus and Adenoviral Vectors
Gregory, S. M., Nazir, S. A., & Metcalf, J. P. (2011) · Future Virology · doi:10.2217/fvl.11.6 · Cited by 89
Metadata
- Authors
- Agerberth, B., Gunne, H., Odeberg, J., Kogner, P., Boman, H. G., & Gudmundsson, G. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-01-03
- Volume
- 92
- Issue
- 1
- Pages
- 195-199
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2050242176
- Cited by
- 503
- References
- 28
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.